SWOT Analysis
Strength: Consolidation of major players has increased their negotiating power with drug manufacturers and pharmacies. Weakness: Regulatory scrutiny over non-transparent business practices of large PBMs.Opportunity: Growing geriatric population and increasing prevalence of chronic diseases is driving the demand for pharmaceutical drugs.Threats: Entry of new agile players with...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian